Hubei Minkang Pharmaceutical Ltd.: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2013)
- $14.7M
- Net Income/Loss (FY2013)
- $127.3K
- Total Assets (FY2013)
- $21.6M
- Total Equity (FY2013)
- $11.4M
- Cash Flows from Operating Activities (FY2013)
- $913.1K
Source: Hubei Minkang Pharmaceutical Ltd. 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
